Laparoscopic Power Morcellators Market Poised to Grow Owing to Rising Incidence of Uterine Fibroids

 

Laparoscopic Power Morcellators Market

The laparoscopic power morcellators market has experienced significant growth in recent years. Laparoscopic power morcellators are electromechanical medical devices that are used to cut tissue or organs into smaller pieces in order to remove specimens from the patient's body through small incisions during a minimally invasive surgery such as laparoscopy. They have various advantages over traditional open surgeries like reduced blood loss, shorter hospital stay and recovery time, less scarring and trauma to tissues. The growing prevalence of hysterectomy procedures for conditions like uterine fibroids and endometriosis has primarily driven the adoption of these devices. Uterine fibroids are non-cancerous tumors that develop in or around the uterus and affect around 70-80% of women by the age of 50. As per estimates, hysterectomies account for nearly one-third of all laparoscopic procedures performed annually in the U.S.

The Global laparoscopic power morcellators market is estimated to be valued at US$ 130.42 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the laparoscopic power morcellators market are Schneider Electric SE, Eaton Corporation PLC, ABB Ltd., Huawei Technologies Co. Ltd., EnerSys, Cummins Inc., Delta Electronics Inc., Myers Power Products Inc., Efore, and Vertiv Co. These players are focusing on new product launches and geographical expansion to consolidate their position. The growing acceptance of minimally invasive procedures worldwide owing to benefits like reduced recovery time, minimal scarring and trauma presents lucrative opportunities for industry players. Several market players are actively involved in funding research on improving the design and functionality of laparoscopic power morcellators to make procedures safer and more efficient. The market is witnessing increased global expansion activities from players looking to tap opportunities in developing regions in Asia Pacific and Latin America with rising medical tourism.

Market Drivers and Restraints

One of the key drivers for the Laparoscopic Power Morcellators Market Size is the rising incidence of uterine fibroids among women globally. As per estimates, uterine fibroids affect 20-40% of women during their reproductive years. Extended working hours and delayed childbearing have contributed to the increasing prevalence of the condition. This is anticipated to drive the demand for minimally invasive hysterectomy procedures using laparoscopic power morcellators. Additionally, the growing geriatric population vulnerable to conditions requiring hysterectomies like endometriosis will also boost adoption. However, product recalls over safety concerns regarding rare risks of spreading unsuspected cancer can negatively impact the market in the short-run. Strict regulatory norms and certification requirements also add to design complexities for industry players. This acts as a key restrain for the growth of the laparoscopic power morcellators market.

Segment Analysis
The laparoscopic power morcellators market is dominanted by gynecologic procedures sub segment. This is because laparoscopic power morcellators are widely used in hysterectomies and myomectomies procedures which accounts for more than 60% of procedures. Heavy bleeding is one of the major post-operative complication of these procedures. Laparoscopic power morcellators help surgeons to remove fibroid tumors or uterus through small incisions, thus reducing post-operative pain and bleeding and enabling faster recovery for patients.

Global Analysis
The North America region dominates the laparoscopic power morcellators market currently. This is attributed to factors such as high incidence of gynecologic conditions like fibroids in countries like United States, availability of advanced medical facilities and growing preference for minimally invasive surgeries. Moreover, heavy funding and investments by government agencies and private players for development of innovative medical devices is also driving the adoption of laparoscopic power morcellators in the region. The Asia Pacific region is expected to witness highest growth during the forecast period owing to rising medical tourism, growing healthcare expenditure and increasing awareness about women's health issues in emerging countries of China and India.

Get more insights on Laparoscopic Power Morcellators Market

Comments

Post a Comment

Popular posts from this blog

Blast Chillers Market Poised to Witness High Growth Owing to Rising Focus on Food Safety

Image
  Blast Chillers Market Blast chillers, also known as shock freeze machines, are appliances used to quickly cool or freeze food items that have been cooked. Blast chillers allow rapid and accurate chilling of cooked or cooked/hot foods quickly to temperatures that inhibit the growth of harmful bacteria. This rapid chilling process helps restaurants, cafes, caterers and foodservice distributors maintain food quality as well as meet critical food safety regulations. Blast chillers help in preserving the look, texture, flavor and nutritional value of foods even after rapid chilling. They extend the shelf life of cooked foods by preventing bacterial growth in the food's temperature danger zone — between 4°C and 60°C. With increasing focus on food safety, hygiene and quality across the foodservice industry, demand for blast chillers has been rising significantly. The Global blast chillers market is estimated to be valued at US$ 2.24 Bn in 2024 and is expected to exhibit a CAGR of 15%...
Read more

Driving Forces and Strategic Insights: Unveiling Growth Opportunities in the Global Pharma 4.0 Market

Image
  Global Pharma 4.0 Market The Global Pharma 4.0 Market is witnessing unprecedented growth driven by several factors. One of the key market drivers is the increasing adoption of digitalization and automation in the pharmaceutical industry. Pharma 4.0 represents the integration of advanced technologies such as artificial intelligence, big data analytics, Internet of Things (IoT), and robotics into pharmaceutical manufacturing and supply chain processes. This integration enhances efficiency, reduces costs, and improves the quality of pharmaceutical products. Additionally, the rising demand for personalized medicine and the need for efficient drug development processes are further fueling the growth of the Global Pharma 4.0 Market. The Global Pharma 4.0 Market is estimated to be valued at   US$ 54.43 Bn in 2024 and is expected to exhibit a CAGR of 18.3% over the forecast period from 2024 to 2031.   Conducting a PEST analysis provides insights into the external facto...
Read more

Navigating Growth: Insights into the Global Flea, Tick, and Heartworm Products Market

Image
  Global Flea, Tick, and Heartworm Products Market The Global Flea, Tick, and Heartworm Products Market have witnessed robust growth in recent years, driven by several key factors. Market drivers such as increasing pet ownership, rising awareness about pet health, and the growing prevalence of flea, tick, and heartworm infections among pets are propelling the demand for related products. Furthermore, advancements in veterinary medicines and the introduction of novel products with improved efficacy are augmenting market growth. The rising disposable income and changing lifestyles, particularly in emerging economies, have also contributed significantly to the expansion of the Global Flea, Tick, and Heartworm Products Market. The Global Flea, Tick, and Heartworm Products Market is estimated to be valued at US$ 3.14 Bn in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031. Conducting a PEST analysis provides valuable insights into the external f...
Read more